Published in
Elsevier, Gynecologic Oncology, 3(116), p. 323-325
DOI: 10.1016/j.ygyno.2009.11.026
Links
- ORCID
- ORCID
- Elsevier
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Single Agent Carboplatin Versus Carboplatin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer: Final Survival Results of a Swog (S0200) Phase 3 Randomized Trial
Journal article published in 2009 by
Maurie Markman,
James Moon,
Sharon Wilczynski,
Ana Maria Lopez 
,
Kendrith M. Rowland,
David P. Michelin,
Victor J. Lanzotti,
Garnet L. Anderson ,
David S. Alberts
,
Kendrith M. Rowland,
David P. Michelin,
Victor J. Lanzotti,
Garnet L. Anderson ,
David S. Alberts
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 